Actinium Pharmaceuticals Inc (ATNM) has fallen 0.61% Wednesday In Premarket Trading

Wednesday, March 20, 2024 08:08 AM | InvestorsObserver Analysts

Mentioned in this article

Actinium Pharmaceuticals Inc (ATNM) is lower by Wednesday morning, with the stock losing -0.61% in pre-market trading to 8.16. ATNM's short-term technical score of 74 indicates that the stock has traded more bullishly over the last month than 74% of stocks on the market. In the Biotechnology industry, which ranks 102 out of 146 industries, the stock ranks higher than 86% of stocks. Actinium Pharmaceuticals Inc has risen 28.89% over the past month, closing at $6.66 on February 21. During this period of time, the stock fell as low as $6.27 and as high as $8.78. ATNM has an average analyst recommendation of Strong Buy. The company has an average price target of $23.72.

ATNM has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on ATNM!
Actinium Pharmaceuticals Inc has a Long-Term Technical rank of 60. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 40% of the market scoring higher. In the Biotechnology industry which is number 67 by this metric, ATNM ranks better than 67% of stocks.

Important Dates for Investors in ATNM:

-Actinium Pharmaceuticals Inc is set to release earnings on 2024-04-01. Over the last 12 months, the company has reported EPS of $-1.92. -We do not have a set dividend date for Actinium Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Actinium Pharmaceuticals Inc (ATNM)

Share this article: